Potential of muvalaplin as a lipoprotein(a) inhibitor

Amanda J. Hooper; P. Mihika S. Fernando; John R. Burnett

doi:10.1080/13543784.2024.2302592

Potential of muvalaplin as a lipoprotein(a) inhibitor

Amanda J. Hooper, P. Mihika S. Fernando, John R. Burnett

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	5-7
Number of pages	3
Journal	Expert Opinion on Investigational Drugs
Volume	33
Issue number	1
DOIs	https://doi.org/10.1080/13543784.2024.2302592
Publication status	Published - 2024

Access to Document

10.1080/13543784.2024.2302592

Cite this

@article{615724c4531241b58a9b7c01ffd68169,

title = "Potential of muvalaplin as a lipoprotein(a) inhibitor",

keywords = "ApoB, LDL, LDL-cholesterol, Lp(a), Lp(a) inhibitor, muvalaplin",

author = "Hooper, {Amanda J.} and Fernando, {P. Mihika S.} and Burnett, {John R.}",

year = "2024",

doi = "10.1080/13543784.2024.2302592",

language = "English",

volume = "33",

pages = "5--7",

journal = "Expert Opinion on Investigational Drugs",

issn = "1354-3784",

publisher = "Informa Healthcare USA",

number = "1",

}

TY - JOUR

T1 - Potential of muvalaplin as a lipoprotein(a) inhibitor

AU - Hooper, Amanda J.

AU - Fernando, P. Mihika S.

AU - Burnett, John R.

PY - 2024

Y1 - 2024

KW - ApoB

KW - LDL

KW - LDL-cholesterol

KW - Lp(a)

KW - Lp(a) inhibitor

KW - muvalaplin

UR - http://www.scopus.com/inward/record.url?scp=85181678283&partnerID=8YFLogxK

U2 - 10.1080/13543784.2024.2302592

DO - 10.1080/13543784.2024.2302592

M3 - Editorial

C2 - 38186354

AN - SCOPUS:85181678283

SN - 1354-3784

VL - 33

SP - 5

EP - 7

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

IS - 1

ER -

Potential of muvalaplin as a lipoprotein(a) inhibitor

Access to Document

Other files and links

Cite this